The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease - Jiao et al. 2020

The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

© 2020 Jiao, Yi, Wang, Zhang, Guo, Du, Gao, Ren, Zhang, Liu, Song and Wang

Frontiers in Aging Neuroscience

Previous
Previous

Plasma Biomarkers Ascertained with Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review

Next
Next

The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease